Skip to main content

Advanced Search

Advanced Search

Current Filters

Filter your query

Publication Types



Newsletter Article


The Consequences of Repeal

  • Congressional Budget Office: Obamacare Repeal Could Lead to 32 Million Fewer Insured Politico by Jennifer Haberkorn—In the first year after repeal, 18 million people would lose insurance and premiums in the non-group market would spike up to 25 percent, the report states. A Republican bill to repeal huge parts of Obamacare would result in 32 million people losing health insurance and would double the price of insurance premiums within a decade, according to a new Congressional Budget Office report.

  • Democrats Use CBO Report to Message Against Obamacare Repeal Roll Call by Lindsey McPherson—Democrats gained a useful messaging tool Tuesday in their efforts to thwart the GOP's plan to dismantle the 2010 health care law, as the Congressional Budget Office released a report saying up to 32 million people would lose their insurance under a previous Republican proposal. The CBO also estimated that marketplace premiums would nearly double under the GOP repeal legislation President Barack Obama vetoed last year. Republicans are using that prior budget reconciliation bill as a model for legislation they are drafting.

  • Obamacare Repeal Threatens Public Health Funding to States USA Today by Jayne O'Donnell—Funding for many state public health and prevention programs is in jeopardy along with insurance for 20 million people as Congress moves to repeal the Affordable Care Act (ACA). While the ACA requires insurers to cover mammograms, colonoscopies, and other preventive care, a less prominent provision authorized a federal fund to prevent the soaring incidence of chronic diseases including diabetes and heart disease. It also funds education targeting college suicides, smoking, and low-income new mothers. The ACA's Prevention and Public Health Fund has survived about 60 votes in Congress, and it was tapped to help pay for the recently enacted 21st Century Cures Act, which funds pharmaceutical research and development and opioid treatment.

Publication Details